ES2071815T3 - Analogos de delecion de los peptidos conocidos como magaininas. - Google Patents

Analogos de delecion de los peptidos conocidos como magaininas.

Info

Publication number
ES2071815T3
ES2071815T3 ES90901287T ES90901287T ES2071815T3 ES 2071815 T3 ES2071815 T3 ES 2071815T3 ES 90901287 T ES90901287 T ES 90901287T ES 90901287 T ES90901287 T ES 90901287T ES 2071815 T3 ES2071815 T3 ES 2071815T3
Authority
ES
Spain
Prior art keywords
amino acid
deletion
magainins
analogs
peptides known
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90901287T
Other languages
English (en)
Inventor
Julio H Cuervo
Richard A Houghten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Application granted granted Critical
Publication of ES2071815T3 publication Critical patent/ES2071815T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN COMPUESTO QUE CONTIENE UN ANALOGO DE SUPRESION DE UNA AMIDA O MAGAIMINA J FINALIZADA EN CARBOXI DE LA FORMULA ESTRUCTURAL UTILIZANDO EL CODIGO (I) DE AMINO-ACIDO DE LETRA UNICA Y DONDE SE OMITE POR LO MENOS UNO DE LOS RESIDUOS AMINO-ACIDOS 15 A TRAVES DE 23; O UN ANALOGO DE SUPRESION DE UNA AMIDA O MAGAIMINA II FINALIZADA EN CARBOXI DE LA FORMULA ESTRUCTURAL UTILIZANDO EL CODIGO (II) DE AMINO-ACIDO DE LETRA UNICA Y DONDE SE OMITE POR LO MENOS UNO DE LOS RESIDUOS DE AMINO-ACIDO 15 A TRAVES DE 23. ESTOS COMPUESTOS PUEDEN UTILIZARSE DE MODO EFECTIVO COMO COMPOSICIONES FARMACEUTICAS.
ES90901287T 1988-12-09 1989-12-05 Analogos de delecion de los peptidos conocidos como magaininas. Expired - Lifetime ES2071815T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/281,981 US4962277A (en) 1988-12-09 1988-12-09 Deletion analogues of magainin peptides

Publications (1)

Publication Number Publication Date
ES2071815T3 true ES2071815T3 (es) 1995-07-01

Family

ID=23079584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90901287T Expired - Lifetime ES2071815T3 (es) 1988-12-09 1989-12-05 Analogos de delecion de los peptidos conocidos como magaininas.

Country Status (9)

Country Link
US (1) US4962277A (es)
EP (1) EP0451190B1 (es)
JP (1) JP2927539B2 (es)
KR (1) KR0149015B1 (es)
AT (1) ATE121755T1 (es)
CA (1) CA2004991C (es)
DE (1) DE68922405T2 (es)
ES (1) ES2071815T3 (es)
WO (1) WO1990006129A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643876A (en) * 1987-03-04 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Biologically active synthetic magainin peptides
SE469132B (sv) * 1989-06-16 1993-05-17 Kabigen Ab Polypeptider och farmaceutisk komposition innehaallande denna
US5912231A (en) * 1989-07-07 1999-06-15 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
US5045531A (en) * 1989-12-18 1991-09-03 Magainin Sciences Inc. Wound treatment employing biologically active ion channel forming peptides and proteins
US5585353A (en) * 1990-02-02 1996-12-17 The Rockefeller University Antibiotic peptides containing D-amino acids
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
EP0472987B1 (en) * 1990-08-10 2005-11-02 Virtual Drug Development, Inc. Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto
US5235038A (en) * 1991-01-22 1993-08-10 Torry Pines Institute For Molecular Studies Deletion and substitution analogues of melittin peptide
WO1992017195A1 (en) * 1991-04-08 1992-10-15 Magainin Pharmaceuticals, Inc. Novel peptide compositions and uses therefor
US5225399A (en) * 1991-04-15 1993-07-06 The Children's Hospital Of Philadelphia Antimicrobial amphiphilic peptides
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides
WO1993001723A1 (en) * 1991-07-25 1993-02-04 Magainin Pharmaceuticals, Inc. Prophylaxis and treatment of adverse oral conditions with biologically active peptides
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
AU5081193A (en) * 1992-08-31 1994-03-29 Magainin Pharmaceuticals, Inc. Treatment of gynecological malignancies with biologically active peptides
US5424290A (en) * 1992-10-26 1995-06-13 Magainin Pharmaceuticals Inc. Biologically active peptides and uses therefor
WO1994012206A1 (en) * 1992-12-03 1994-06-09 Magainin Pharmaceuticals, Inc. Treatment of dermatological malignancies with biologically active peptides
US5847047A (en) * 1993-06-22 1998-12-08 E. I. Du Pont De Nemours And Company Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type
WO1995011670A1 (en) * 1993-10-25 1995-05-04 The Liposome Company, Inc. Liposomal defensins
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
CN114634553B (zh) * 2022-04-27 2024-03-08 贵州医科大学 阳离子肽c9及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds

Also Published As

Publication number Publication date
CA2004991A1 (en) 1990-06-09
EP0451190B1 (en) 1995-04-26
KR910700062A (ko) 1991-03-13
DE68922405T2 (de) 1996-01-04
ATE121755T1 (de) 1995-05-15
KR0149015B1 (ko) 1998-10-15
WO1990006129A1 (en) 1990-06-14
JP2927539B2 (ja) 1999-07-28
EP0451190A4 (en) 1992-05-20
US4962277A (en) 1990-10-09
JPH04502159A (ja) 1992-04-16
DE68922405D1 (de) 1995-06-01
EP0451190A1 (en) 1991-10-16
CA2004991C (en) 1999-12-07

Similar Documents

Publication Publication Date Title
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
DK358384A (da) Farmaceutiske midler til bekaempelse af diabetes mellitus
SE8605189L (sv) Nya kalcitoninderivat
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
DE69012901D1 (de) Hämoregulierende Peptide.
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
AR004497A1 (es) Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica.
ES2112921T3 (es) Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.
SE8200757L (sv) Biologiskt aktiva peptider
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
NO881661D0 (no) Humane rhinoviruspeptider.
KR890700673A (ko) 돼지 성장호르몬 아날로그
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
DK87090D0 (da) Vasotocin-derivater og farmaceutiske midler indeholdende saadanne derivater
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
SE7909653L (sv) Tyrosylerade proinsulin c-peptidderivat
BR8804486A (pt) Tinoalcanodifosfonatos de o-alquil-o-(6-metil-2-alquil-pirimidino-4-ilo),processo para sua preparacao,composicoes inseticidas,processo para o combate a atropodes e para a preparacao de artropodicidas
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.
ES8704185A1 (es) Procedimiento para preparar derivados de aminoacidos
NO931091L (no) Analoger av sykloinopeptid a og anvendelse derav

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451190

Country of ref document: ES